Northwestern Mutual Wealth Management
VYGR icon

Northwestern Mutual Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Buy
+22
New +$83 ﹤0.01% 4004
2026
Q1 		– Sell
-28
Closed -$110 – 4489
2025
Q4 		$110 Buy
+28
New +$124 ﹤0.01% 3847
2016
Q4 		– Sell
-26
Closed – – 2519
2016
Q3 		$0 Buy
+26
New +$352 ﹤0.01% 2343

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northwestern Mutual Wealth Management's VYGR Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 22 shares worth $78. The stake represents ﹤0.01% of the portfolio and ranks #4004 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in VYGR as recently as Q4 2025.

Northwestern Mutual Wealth Management first reported a position in VYGR in Q3 2016 and has held it in 3 quarters since. The position peaked at $110 in Q4 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Northwestern Mutual Wealth Management held 22 shares of Voyager Therapeutics worth $78 as of Q2 2026.
  • Voyager Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4004 holding.
  • Northwestern Mutual Wealth Management first reported a position in Voyager Therapeutics in Q3 2016 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Voyager Therapeutics position peaked at $110 in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.